Morphine Hcl Sterop (Morphine Hydrochloride)

Morphine acts as a full agonist at μ‑opioid receptors in the central nervous system. By binding to these receptors, it inhibits the release of neurotransmitters that transmit pain signals, reduces neuronal excitability, and alters the perception of pain, providing effective analgesia.

The specific dose is determined by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, route of administration, and individual clinical factors. Dosage adjustments follow local guidelines and regulatory requirements, and the prescriber sets the exact regimen.

Safety of morphine during pregnancy and lactation is not well established and is generally classified as Category C/unknown. Use is reserved for situations where the therapeutic benefit outweighs potential risks, and only under strict medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Compared with alternatives such as fentanyl or oxycodone, morphine has a well‑characterised pharmacokinetic profile and a longer duration of action when given epidurally. It is widely used and familiar to clinicians, though it may cause more pronounced constipation and requires careful titration to avoid respiratory depression.

Store Morphine Hcl Sterop at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, light and extreme temperatures, and ensure the container is securely sealed to maintain sterility.

The product is supplied as a sterile injectable solution and may be administered by epidural, intramuscular or intrathecal injection. Administration must be performed by qualified healthcare professionals using aseptic technique and in accordance with local prescribing guidelines.

The most critical risks include respiratory depression, severe hypotension, profound sedation leading to coma, and the potential for dependence or abuse. Patients should be closely monitored for signs of respiratory compromise, especially after dose initiation or escalation.

Morphine Hcl Sterop is contraindicated in patients with known hypersensitivity to morphine or other opioids, those with significant respiratory depression, untreated severe asthma, or paralytic ileus. Caution is also advised for individuals with head injury, increased intracranial pressure, or a history of substance misuse.